RoukenBio
PrivateLast Round
Private Equity
Nov 2, 2023
Total Funding Raised
$710,000
Company Overview
RoukenBio is a biotechnology company that provides immunology-centered contract research organization (CRO) services for biopharmaceutical and drug development companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RoukenBio Comparables
Compare RoukenBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellomatics Biosciences | 82% | |
| Concept Life Sciences | 81% | |
| InnoSer Nederland | 78% |
RoukenBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Nov 2, 2023 | ||||
| Grant | Dec 1, 2020 | ||||
| Grant | Aug 4, 2020 | ||||
| VC Round | Jun 3, 2019 |
Key People
Founding team and executive leadership
RoukenBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NorthEdge Capital | Private Equity |
| Innovate UK | Grant |
| UK Steel Enterprise | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 80% MoM, reaching 10K.
- Dec 1, 2020
$270K grant received from Innovate UK.
RoukenBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RoukenBio's valuation, stock price, and market status.
Is RoukenBio a public or private company?
RoukenBio is a private company.
What is the current stock price of RoukenBio?
RoukenBio is a private company with no public stock price. No recent secondary market data is available.
How much is RoukenBio worth (valuation)?
Valuation information for RoukenBio is not publicly available.
Can I buy RoukenBio stock?
RoukenBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RoukenBio's last funding round?
RoukenBio's most recent funding round was Private Equity on November 2, 2023.
Who are the main investors in RoukenBio?
Key investors in RoukenBio include NorthEdge Capital, UK Steel Enterprise.
Will RoukenBio IPO soon?
No public IPO plans have been announced for RoukenBio.
How can I track RoukenBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RoukenBio's secondary market activity and sign up for updates.